News

BioBridge Global Announces Formation Of Regenerative Medicine Advisory Board

FOR IMMEDIATE RELEASE July 12, 2018 Media Contact: Mary Uhlig, 210-731-5519 mary.uhlig@biobridgeglobal.org   BioBridge Global Announces Formation Of Regenerative Medicine Advisory Board   SAN ANTONIO, Texas – BioBridge Global today announced the formation of a new Regenerative Medicine Advisory Board, composed of industry leaders with a wide range of scientific,

Read More »

Versiti among first in U.S. to offer pathogen reduced platelets

MILWAUKEE, Feb. 21, 2018 /PRNewswire-USNewswire/ — Versiti, Inc., a national leader in blood health innovation, is among the first in the United States to provide pathogen reduced platelets that reduce the risk of infection and lead to safer transfusions for patients. Versiti produced its first pathogen reduced platelets in January

Read More »

BloodCenter of Wisconsin launches breakthrough FDA approved leukemia test

BCW and Abbott Laboratories’ collaboration will help to advance personalized medicine by better identifying patients that could benefit from new FDA approved medication MILWAUKEE, Aug. 29, 2017 /PRNewswire-USNewswire/ — BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti, is the first to offer testing using Abbott Laboratories’ RealTime IDH2 assay that

Read More »